| 7001 | Urbanicity (confirmatory factor analysis Factor 4) | GCST90309339 | 0.04 |
| 7002 | Esophageal adenocarcinoma | GCST003739 | 0.04 |
| 7003 | CALCOCO1/TJAP1 ratio | GCST90313611 | 0.04 |
| 7004 | mean corpuscular hemoglobin (MCH, mean, inv-norm transformed) | GCST90475444 | 0.04 |
| 7005 | CYB5R2 levels | GCST90468937 | 0.04 |
| 7006 | Random glucose levels | GCST90271557 | 0.04 |
| 7007 | TIMD4 levels | GCST90470866 | 0.04 |
| 7008 | PDGFRA levels | GCST90470191 | 0.04 |
| 7009 | Otitis media and Eustachian tube disorders (PheCode 381) | GCST90475902 | 0.04 |
| 7010 | Main speciality of consultant (recoded) - Anaesthetics | Summary Administration | UKBB00000413 | 0.04 |
| 7011 | Phospholipids to total lipids ratio in small HDL | GCST90092953 | 0.04 |
| 7012 | wg rh intensity-contrast lateraloccipital | GCST90003837 | 0.04 |
| 7013 | ADAMTS16 levels | GCST90468224 | 0.04 |
| 7014 | Hypertensive chronic kidney disease (PheCode 401.22) | GCST90475927 | 0.04 |
| 7015 | Height decline (log-difference score) | GCST90565853 | 0.04 |
| 7016 | AFP levels | GCST90468250 | 0.04 |
| 7017 | CTSZ/SMPDL3A ratio | GCST90314322 | 0.03 |
| 7018 | ATP5IF1/LYN ratio | GCST90313389 | 0.03 |
| 7019 | NCR1 levels | GCST90470009 | 0.03 |
| 7020 | F7/PROC ratio | GCST90314744 | 0.03 |
| 7021 | Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney disease | GCST90266045 | 0.03 |
| 7022 | TANK levels | GCST90470803 | 0.03 |
| 7023 | Other chronic obstructive pulmonary disease | Chronic lower respiratory diseases | UKBB00000604 | 0.03 |
| 7024 | Creatinine levels in bottom 99% of individuals by creatinine levels | GCST90566733 | 0.03 |
| 7025 | ERBB2/PTPRF ratio | GCST90314688 | 0.03 |
| 7026 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T41 | ECGA000041 | 0.03 |
| 7027 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06) | GCST90291582 | 0.03 |
| 7028 | CA4/PECAM1 ratio | GCST90313586 | 0.03 |
| 7029 | 2-aminobutyrate levels | GCST90243584 | 0.03 |
| 7030 | aparc-a2009s lh volume G-parietal-sup | GCST90002951 | 0.03 |
| 7031 | SRSF7 levels | GCST90242771 | 0.03 |
| 7032 | IDP dMRI ProbtrackX L3 ptr r | GCST90004320 | 0.03 |
| 7033 | Creatinine levels | GCST90132719 | 0.03 |
| 7034 | Preeclampsia or other maternal hypertension (maternal genotype effect) | GCST90269904 | 0.03 |
| 7035 | GFAP levels | GCST90469325 | 0.03 |
| 7036 | Prostate cancer | GCST90274716 | 0.03 |
| 7037 | Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels | GCST90060277 | 0.03 |
| 7038 | TBL1X levels | GCST90470815 | 0.03 |
| 7039 | APBB1IP levels | GCST90468327 | 0.03 |
| 7040 | PLXNA4/SUSD1 ratio | GCST90315689 | 0.03 |
| 7041 | CNTN5/ROBO2 ratio | GCST90314166 | 0.03 |
| 7042 | Fracture of hand or wrist (PheCode 804) | GCST90476281 | 0.03 |
| 7043 | CNTN2 levels | GCST90468804 | 0.03 |
| 7044 | Triacylglycerol_54:3_[M+NH4]1+ levels | GCST90060541 | 0.03 |
| 7045 | Cholesterol to Total Lipids in Large HDL percentage | GCST90497730 | 0.03 |
| 7046 | CLEC1B/SNAP29 ratio | GCST90314103 | 0.03 |
| 7047 | DTI autoptx L1 atr l tract | GCST90385141 | 0.03 |
| 7048 | DKK1/PTPN6 ratio | GCST90314478 | 0.03 |
| 7049 | Phosphatidylcholine (34:5) levels | GCST90024286 | 0.03 |
| 7050 | Percent liver fat | GCST90016673 | 0.03 |
| 7051 | Cholesterol levels in medium HDL | GCST90092892 | 0.03 |
| 7052 | Omega-3 fatty acids levels | GCST90499145 | 0.03 |
| 7053 | ADGRG2/ITGB1 ratio | GCST90313185 | 0.03 |
| 7054 | SAMD9L levels | GCST90470524 | 0.03 |
| 7055 | CPA1/CPB1 ratio | GCST90314202 | 0.03 |
| 7056 | DTI TBSS MD Body of corpus callosum | GCST90384575 | 0.03 |
| 7057 | DPT levels | GCST90469036 | 0.03 |
| 7058 | Hands-free device/speakerphone use with mobile phone in last 3 month | Electronic device use | UKBB00000304 | 0.03 |
| 7059 | RAB27B levels | GCST90470405 | 0.03 |
| 7060 | IDP T1 FAST ROIs R cerebellum VI | GCST90002568 | 0.03 |
| 7061 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502632 | 0.03 |
| 7062 | GADD45GIP1 levels | GCST90469293 | 0.03 |
| 7063 | MTSS2 levels | GCST90469961 | 0.03 |
| 7064 | NUB1/SRPK2 ratio | GCST90315573 | 0.03 |
| 7065 | NUDT16 levels | GCST90470105 | 0.03 |
| 7066 | CPQ levels | GCST90468846 | 0.03 |
| 7067 | Hemangioma of skin and subcutaneous tissue (PheCode 228.1) | GCST90475633 | 0.03 |
| 7068 | Sphingomyelin_39:1_[M+H]1+ levels | GCST90060328 | 0.03 |
| 7069 | PLAT levels | GCST90470250 | 0.03 |
| 7070 | X-08402 levels | GCST90243538 | 0.03 |
| 7071 | MAVS/MZT1 ratio | GCST90315391 | 0.03 |
| 7072 | KLK11 levels | GCST90469697 | 0.03 |
| 7073 | CCN2/EDAR ratio | GCST90313711 | 0.03 |
| 7074 | Vaginitis/vulvovaginitis/vulvitis/abscess of vulva | FING00001412 | 0.03 |
| 7075 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T100 | ECGU000100 | 0.03 |
| 7076 | CLPS levels | GCST90468786 | 0.03 |
| 7077 | Snoring | GCST009763 | 0.03 |
| 7078 | 1-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levels | GCST90200057 | 0.03 |
| 7079 | Docosahexaenoic acid to total fatty acids percentage | GCST90502281 | 0.03 |
| 7080 | ENG/PEAR1 ratio | GCST90314649 | 0.03 |
| 7081 | Prescriptions - gliclazide | sulfonylurea,diabetes | UKBB00000684 | 0.03 |
| 7082 | Benign neoplasm: Adrenal gland | FING00000164 | 0.03 |
| 7083 | Physical activity (Total log acceleration 2am-4am) | GCST90061410 | 0.03 |
| 7084 | Blood cell traits latent factor 16 (white cell) | GCST90559258 | 0.03 |
| 7085 | DARS1 levels | GCST90468947 | 0.03 |
| 7086 | LRRC25 levels | GCST90469801 | 0.03 |
| 7087 | LRP11/ROR1 ratio | GCST90315330 | 0.03 |
| 7088 | DTI autoptx L3 fmi tract | GCST90385204 | 0.03 |
| 7089 | CIAPIN1 levels | GCST90468753 | 0.03 |
| 7090 | HARS1 levels | GCST90469430 | 0.03 |
| 7091 | LAIR1 levels | GCST90469728 | 0.03 |
| 7092 | S100P levels | GCST90470520 | 0.03 |
| 7093 | Actinic keratosis (PheCode 702.1) | GCST90476204 | 0.03 |
| 7094 | Heart rate variability (root mean square of successive differences) | GCST90281263 | 0.03 |
| 7095 | ICD10 N97.8: Female infertility of other origin | GCST90454225 | 0.03 |
| 7096 | Calculus of lower urinary tract (PheCode 594.2) | GCST90476146 | 0.03 |
| 7097 | Sphingomyelin_36:1_[M+H]1+ levels | GCST90060266 | 0.03 |
| 7098 | APP/FKBP1B ratio | GCST90313323 | 0.03 |
| 7099 | Diacylglycerol_38:5_[M+H-H2O]1+ levels | GCST90060200 | 0.03 |
| 7100 | Type 1 diabetes with ketoacidosis (PheCode 250.11) | GCST90475662 | 0.03 |
| 7101 | DTI TBSS L1 Cingulum cingulate gyrus L | GCST90384463 | 0.03 |
| 7102 | FOXO1/NUB1 ratio | GCST90314874 | 0.03 |
| 7103 | CCL13/CCL2 ratio | GCST90313675 | 0.03 |
| 7104 | Other ulcerative colitis | FING00001117 | 0.03 |
| 7105 | Left-hemisphere visual network to right-hemisphere visual network white-matter structural connectivity | GCST90302655 | 0.03 |
| 7106 | DTI autoptx L1 ilf l tract | GCST90385153 | 0.03 |
| 7107 | NCK2/PLA2G4A ratio | GCST90315524 | 0.03 |
| 7108 | Sleep apnea | neurological | UKBB00000774 | 0.03 |
| 7109 | FLI1 levels | GCST90469247 | 0.03 |
| 7110 | Hyperplasia of prostate (PheCode 600) | GCST90476153 | 0.03 |
| 7111 | ALCAM/MSR1 ratio | GCST90313240 | 0.03 |
| 7112 | Esophagitis, GERD and related diseases (PheCode 530.1) | GCST90476046 | 0.03 |
| 7113 | Prostate cancer | GCST90018685 | 0.03 |
| 7114 | DARS1/MAP4K5 ratio | GCST90314404 | 0.03 |
| 7115 | BST2/MME ratio | GCST90313539 | 0.03 |
| 7116 | Stenosis and insufficiency of lacrimal passages | FING00001334 | 0.03 |
| 7117 | YARS1 levels | GCST90471087 | 0.03 |
| 7118 | Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levels | GCST90060325 | 0.03 |
| 7119 | Glycated hemoglobin levels | GCST90002243 | 0.03 |
| 7120 | IDP dMRI ProbtrackX FA fma | GCST90003935 | 0.03 |
| 7121 | Carnitine levels | GCST90239991 | 0.03 |
| 7122 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T74 | ECGU000074 | 0.03 |
| 7123 | Gastroesophageal reflux disease | GCST90000514 | 0.03 |
| 7124 | Sphingomyelin_36:2_[M+H]1+ levels | GCST90060263 | 0.03 |
| 7125 | ANGPT1/APP ratio | GCST90313260 | 0.03 |
| 7126 | SLC4A1 levels | GCST90470663 | 0.03 |
| 7127 | Other alveolar and parietoalveolar pneumonopathy (PheCode 504) | GCST90476033 | 0.03 |
| 7128 | HippSubfield rh volume Whole-hippocampal-body | GCST90002709 | 0.03 |
| 7129 | Urine X-24796 levels in chronic kidney disease | GCST90266800 | 0.03 |
| 7130 | OMG levels | GCST90470124 | 0.03 |
| 7131 | IDP T1 FAST ROIs L cerebellum IX | GCST90002584 | 0.03 |
| 7132 | ANG/RARRES2 ratio | GCST90313271 | 0.03 |
| 7133 | SPINT2/TNFSF13 ratio | GCST90315879 | 0.03 |
| 7134 | IDP dMRI TBSS L1 Cerebral peduncle L | GCST90004090 | 0.03 |
| 7135 | Saturated fatty acids levels | GCST90502675 | 0.03 |
| 7136 | IDP T1 SIENAX peripheral grey unnormalised volume | GCST90002427 | 0.03 |
| 7137 | DTI TBSS L2 Fornix | GCST90384481 | 0.03 |
| 7138 | IDP dMRI TBSS ICVF Superior cerebellar peduncle R | GCST90004339 | 0.03 |
| 7139 | Treatment/medication code - omeprazole | Medications | UKBB00000852 | 0.03 |
| 7140 | IDP T1 SIENAX peripheral grey normalised volume | GCST90002426 | 0.03 |
| 7141 | ABL1/DNMBP ratio | GCST90313149 | 0.03 |
| 7142 | CASP3/PDGFA ratio | GCST90313637 | 0.03 |
| 7143 | DNAJB6 levels | GCST90469014 | 0.03 |
| 7144 | CC2D1A/WWP2 ratio | GCST90313668 | 0.03 |
| 7145 | TIA1 levels | GCST90470862 | 0.03 |
| 7146 | CANT1/ROR1 ratio | GCST90313620 | 0.03 |
| 7147 | AXIN1/BACH1 ratio | GCST90313400 | 0.03 |
| 7148 | Ever thought that life not worth living | Self-harm behaviours | UKBB00000225 | 0.03 |
| 7149 | Eosinophil count variance | GCST90565689 | 0.03 |
| 7150 | CLEC10A levels | GCST90468763 | 0.03 |
| 7151 | total cholesterol (maximum, inv-norm transformed) | GCST90476418 | 0.03 |
| 7152 | Cholesteryl Esters to Total Lipids in Large HDL percentage | GCST90497763 | 0.03 |
| 7153 | IDP dMRI TBSS L3 Posterior corona radiata L | GCST90004198 | 0.03 |
| 7154 | Epilepsy | FING00000511 | 0.03 |
| 7155 | CD84/DKK1 ratio | GCST90313911 | 0.03 |
| 7156 | CD83/LAMP3 ratio | GCST90313906 | 0.03 |
| 7157 | ALCAM/CNTN1 ratio | GCST90313235 | 0.03 |
| 7158 | PTPN1/WWP2 ratio | GCST90315746 | 0.03 |
| 7159 | CRADD/SIRT2 ratio | GCST90314243 | 0.03 |
| 7160 | Dried fruit consumption | GCST90132980 | 0.03 |
| 7161 | ADA2/COMP ratio | GCST90313166 | 0.03 |
| 7162 | C1QTNF5 levels | GCST90468489 | 0.03 |
| 7163 | PLIN1 levels | GCST90470258 | 0.03 |
| 7164 | TEK levels | GCST90470829 | 0.03 |
| 7165 | Average diameter for HDL particles | GCST90497454 | 0.03 |
| 7166 | CD79B/ICAM3 ratio | GCST90313901 | 0.03 |
| 7167 | CXCL14 levels | GCST90468927 | 0.03 |
| 7168 | Blood cell traits latent factor 20 (red cell) | GCST90559262 | 0.03 |
| 7169 | NMT1 levels | GCST90470059 | 0.03 |
| 7170 | PALM2 levels | GCST90470152 | 0.03 |
| 7171 | Septal defects | FING00001293 | 0.03 |
| 7172 | PCDH1/TNFRSF11A ratio | GCST90315608 | 0.03 |
| 7173 | wg rh intensity-contrast supramarginal | GCST90003857 | 0.03 |
| 7174 | EBAG9 levels | GCST90469059 | 0.03 |
| 7175 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 7.99_210.09) | GCST90291312 | 0.03 |
| 7176 | AARSD1/UBAC1 ratio | GCST90313135 | 0.03 |
| 7177 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T477 | ECGA000477 | 0.03 |
| 7178 | SUSD1/THPO ratio | GCST90315899 | 0.03 |
| 7179 | Arabitol/xylitol levels | GCST90200011 | 0.03 |
| 7180 | CA4/TNFSF12 ratio | GCST90313589 | 0.03 |
| 7181 | Asthma | GCST90468112 | 0.03 |
| 7182 | CES3 levels | GCST90468720 | 0.03 |
| 7183 | DCTN1/FXN ratio | GCST90314430 | 0.03 |
| 7184 | Gastric polyp | GCST90018630 | 0.03 |
| 7185 | DIPK2B levels | GCST90468996 | 0.03 |
| 7186 | DSG3/DSG4 ratio | GCST90314558 | 0.03 |
| 7187 | GIPC3 levels | GCST90469348 | 0.03 |
| 7188 | CCL5/RARRES2 ratio | GCST90313704 | 0.03 |
| 7189 | Processed meat consumption | GCST90132995 | 0.03 |
| 7190 | ANXA11 levels | GCST90468315 | 0.03 |
| 7191 | ESAM/VSIR ratio | GCST90314721 | 0.03 |
| 7192 | FADD levels | GCST90469180 | 0.03 |
| 7193 | CCL4 levels | GCST90274770 | 0.03 |
| 7194 | XXYLT1 levels | GCST90243370 | 0.03 |
| 7195 | Colorectal cancer (PheCode 153) | GCST008372 | 0.03 |
| 7196 | Influenza and pneumonia | FING00000679 | 0.03 |
| 7197 | LRRFIP1 levels | GCST90469805 | 0.03 |
| 7198 | Symptoms involving digestive system (PheCode 561) | GCST90476069 | 0.03 |
| 7199 | MANF/TXNDC5 ratio | GCST90315370 | 0.03 |
| 7200 | PLAU/PLAUR ratio | GCST90315674 | 0.03 |
| 7201 | F2R/ITGB1BP2 ratio | GCST90314731 | 0.03 |
| 7202 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T471 | ECGA000471 | 0.03 |
| 7203 | CCL17 levels | GCST90468569 | 0.03 |
| 7204 | Congestive heart failure; nonhypertensive (PheCode 428) | GCST90475981 | 0.03 |
| 7205 | CPB1/CTRC ratio | GCST90314209 | 0.03 |
| 7206 | GERD (PheCode 530.11) | GCST90476047 | 0.03 |
| 7207 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T478 | ECGA000478 | 0.03 |
| 7208 | Sleep disorders (PheCode 327) | GCST90475823 | 0.03 |
| 7209 | Alcohol abuse, main dg (more control exclusions) | FING00000049 | 0.03 |
| 7210 | aseg lh intensity Thalamus-Proper | GCST90003768 | 0.03 |
| 7211 | Allergic disease (asthma, hay fever or eczema) | GCST005038 | 0.03 |
| 7212 | Treatment/medication code - metformin | Medications | UKBB00000851 | 0.03 |
| 7213 | Treatment/medication code - aspirin | Medications | UKBB00000841 | 0.03 |
| 7214 | ACVRL1/SCARB2 ratio | GCST90313157 | 0.03 |
| 7215 | IDP T1 FIRST left pallidum volume | GCST90002442 | 0.03 |
| 7216 | Other contact dermatitis | FING00000990 | 0.03 |
| 7217 | CSF1/IL10RB ratio | GCST90314284 | 0.03 |
| 7218 | Mineral and other dietary supplements - Zinc | Medication | UKBB00000476 | 0.03 |
| 7219 | Serum 25-Hydroxyvitamin D levels (conditioned on BMI) | GCST90000616 | 0.03 |
| 7220 | DTI TBSS MD Sagittal stratum L | GCST90384603 | 0.03 |
| 7221 | UFC1 levels | GCST90243245 | 0.03 |
| 7222 | IDP dMRI ProbtrackX ICVF ptr r | GCST90004395 | 0.03 |
| 7223 | wg rh intensity-contrast lateralorbitofrontal | GCST90003838 | 0.03 |
| 7224 | ERBIN levels | GCST90469142 | 0.03 |
| 7225 | Disorders of synovium and tendon | FING00000462 | 0.03 |
| 7226 | HPCAL1/NUDC ratio | GCST90315074 | 0.03 |
| 7227 | BSG/IL12A_IL12B ratio | GCST90313532 | 0.03 |
| 7228 | CGREF1/FAM3C ratio | GCST90314032 | 0.03 |
| 7229 | LCP1 levels | GCST90469748 | 0.03 |
| 7230 | GDNF levels | GCST90274792 | 0.03 |
| 7231 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T231 | ECGU000231 | 0.03 |
| 7232 | ITGA5/VCAM1 ratio | GCST90315206 | 0.03 |
| 7233 | aparc-a2009s rh area G-postcentral | GCST90003398 | 0.03 |
| 7234 | wg rh intensity-contrast inferiortemporal | GCST90003835 | 0.03 |
| 7235 | Right ventricular peak ejection rate | GCST90268120 | 0.03 |
| 7236 | RHOC/TBCB ratio | GCST90315774 | 0.03 |
| 7237 | HDL cholesterol | GCST002223 | 0.03 |
| 7238 | MSLN levels | GCST90469948 | 0.03 |
| 7239 | DCTN6 levels | GCST90468960 | 0.03 |
| 7240 | CETN3 levels | GCST90468722 | 0.03 |
| 7241 | CXCL11/CXCL13 ratio | GCST90314333 | 0.03 |
| 7242 | NFATC1 levels | GCST90470033 | 0.03 |
| 7243 | Mosaic chromosomal alteration of the X chromosome | GCST90165287 | 0.03 |
| 7244 | NPHS1 levels | GCST90470070 | 0.03 |
| 7245 | FUT8/TNFSF12 ratio | GCST90314894 | 0.03 |
| 7246 | APLP1 levels | GCST90468330 | 0.03 |
| 7247 | PON3 levels | GCST90470287 | 0.03 |
| 7248 | CD69/CEP43 ratio | GCST90313867 | 0.03 |
| 7249 | ANXA1 levels | GCST90468316 | 0.03 |
| 7250 | TOP2B levels | GCST90470934 | 0.03 |
| 7251 | COMP/ICAM1 ratio | GCST90314189 | 0.03 |
| 7252 | BID levels | GCST90468444 | 0.03 |
| 7253 | Other bacterial intestinal infections | FING00000969 | 0.03 |
| 7254 | DIABLO/MITD1 ratio | GCST90314467 | 0.03 |
| 7255 | Cirrhosis | GCST90319877 | 0.03 |
| 7256 | CDH5 levels | GCST90468676 | 0.03 |
| 7257 | APOBR levels | GCST90468334 | 0.03 |
| 7258 | TPD52L2 levels | GCST90470942 | 0.03 |
| 7259 | APOA2 levels | GCST90468332 | 0.03 |
| 7260 | ACY1/DCXR ratio | GCST90313162 | 0.03 |
| 7261 | DTI autoptx MD unc r tract | GCST90385246 | 0.03 |
| 7262 | CD79B/FCRL1 ratio | GCST90313899 | 0.03 |
| 7263 | IDP T1 FAST ROIs R front operc cortex | GCST90002532 | 0.03 |
| 7264 | PRSS22 levels | GCST90470341 | 0.03 |
| 7265 | ThalamNuclei lh volume CM | GCST90002718 | 0.03 |
| 7266 | PLIN1/SNCG ratio | GCST90315677 | 0.03 |
| 7267 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T466 | ECGU000466 | 0.03 |
| 7268 | Phospholipids to total lipids in large LDL percentage (UKB data field 23614) | GCST90269711 | 0.03 |
| 7269 | RIDA levels | GCST90470469 | 0.03 |
| 7270 | Osteoarthritis (self-reported) | GCST005811 | 0.03 |
| 7271 | ESAM/SORT1 ratio | GCST90314716 | 0.03 |
| 7272 | Prescriptions - sulfonylurea|diabetes | UKBB00000703 | 0.03 |
| 7273 | Non-cancer illness code, self-reported - high cholesterol | Medical conditions | UKBB00000516 | 0.03 |
| 7274 | Phospholipids in IDL | GCST90497626 | 0.03 |
| 7275 | ITGB1/VASN ratio | GCST90315232 | 0.03 |
| 7276 | GLO1 levels | GCST90469358 | 0.03 |
| 7277 | MAN2B2 levels | GCST90469844 | 0.03 |
| 7278 | Urine proline levels in chronic kidney disease | GCST90265873 | 0.03 |
| 7279 | aseg global volume CC-Anterior | GCST90002611 | 0.03 |
| 7280 | Clonal haematopoiesis of indeterminate potential (ASXL1 mutation) | GCST90165259 | 0.03 |
| 7281 | Phospholipids to Total Lipids in Large HDL percentage | GCST90497863 | 0.03 |
| 7282 | CDH17/DSG2 ratio | GCST90313939 | 0.03 |
| 7283 | STK24 levels | GCST90470766 | 0.03 |
| 7284 | APP/BIN2 ratio | GCST90313316 | 0.03 |
| 7285 | Deferral due to hypohemoglobinemia in blood donors | GCST90104113 | 0.03 |
| 7286 | Volume of right central nucleus | GCST90474916 | 0.03 |
| 7287 | CELA3A/CPA1 ratio | GCST90314009 | 0.03 |
| 7288 | aparc-a2009s rh area S-intrapariet+P-trans | GCST90003426 | 0.03 |
| 7289 | RILP levels | GCST90470471 | 0.03 |
| 7290 | Bread type: Wholemeal or wholegrain (UKB data field 1448_3) | GCST90132966 | 0.03 |
| 7291 | Cholesteryl Esters to Total Lipids in Small HDL percentage | GCST90499406 | 0.03 |
| 7292 | Chained arithmetic | Fluid intelligence / reasoning | UKBB00000126 | 0.03 |
| 7293 | Bipolar and major depression status - No Bipolar or Depression | Mental health | UKBB00000094 | 0.03 |
| 7294 | ALPP levels | GCST90468286 | 0.03 |
| 7295 | Plasma betaine levels in chronic kidney disease | GCST90264858 | 0.03 |
| 7296 | NUDT5/TXNRD1 ratio | GCST90315582 | 0.03 |
| 7297 | Diabetes, insulin treatment (Kela reimbursement) (more control exclusions) | FING00000410 | 0.03 |
| 7298 | Non-cancer illness code, self-reported - asthma | Medical conditions | UKBB00000506 | 0.03 |
| 7299 | ADGRE1 levels | GCST90468236 | 0.03 |
| 7300 | ESAM levels | GCST90469152 | 0.03 |
| 7301 | PI3 levels | GCST90470230 | 0.03 |
| 7302 | CLEC1B/VSIR ratio | GCST90314106 | 0.03 |
| 7303 | KLF4 levels | GCST90469694 | 0.03 |
| 7304 | Ventricular arrhythmia | GCST90018720 | 0.03 |
| 7305 | Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418) | GCST90132986 | 0.03 |
| 7306 | X-21736 levels | GCST90200584 | 0.03 |
| 7307 | ZFYVE19 levels | GCST90471098 | 0.03 |
| 7308 | STX4 levels | GCST90470772 | 0.03 |
| 7309 | Omega-6 fatty acids to total fatty acids percentage | GCST90502545 | 0.03 |
| 7310 | ALOX15B levels | GCST90617547 | 0.03 |
| 7311 | rfMRI amplitudes (ICA100 node 11) | GCST90004599 | 0.02 |
| 7312 | DTI TBSS MD Posterior limb of internal capsule L | GCST90384591 | 0.02 |
| 7313 | DKK1/SERPINE1 ratio | GCST90314480 | 0.02 |
| 7314 | PFKFB2 levels | GCST90470215 | 0.02 |
| 7315 | Soy sauce liking | GCST90094844 | 0.02 |
| 7316 | Other maternal disorders predominantly related to pregnancy | FING00001069 | 0.02 |
| 7317 | INPP1/NT5C3A ratio | GCST90315177 | 0.02 |
| 7318 | Cereal type - Muesli | Diet | UKBB00000123 | 0.02 |
| 7319 | ThalamNuclei rh volume VAmc | GCST90002747 | 0.02 |
| 7320 | ENO2/TACC3 ratio | GCST90314670 | 0.02 |
| 7321 | Other demyelinating diseases of the central nervous system | FING00000995 | 0.02 |
| 7322 | Arm fat percentage (right) | Impedance measures | UKBB00000046 | 0.02 |
| 7323 | ITGB1BP2/USP8 ratio | GCST90315223 | 0.02 |
| 7324 | White blood cell (leukocyte) count | Blood count | UKBB00000913 | 0.02 |
| 7325 | Spread type: Butter and margarine vs never use spread (UKB data field 1428) | GCST90132948 | 0.02 |
| 7326 | Oral glucose tolerance test-1h | GCST90566422 | 0.02 |
| 7327 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502580 | 0.02 |
| 7328 | NT5C3A/SCRN1 ratio | GCST90315569 | 0.02 |
| 7329 | Cholesteryl ester levels in medium HDL | GCST90092894 | 0.02 |
| 7330 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470 | ECGU000470 | 0.02 |
| 7331 | COQ7 levels | GCST90468831 | 0.02 |
| 7332 | Total lipid levels in HDL | GCST90092825 | 0.02 |
| 7333 | aparc-a2009s rh thickness G-oc-temp-med-Lingual | GCST90003698 | 0.02 |
| 7334 | T1 FreeSurfer DK lh lingual thickness | GCST90385634 | 0.02 |
| 7335 | SEMA3G levels | GCST90470571 | 0.02 |
| 7336 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502181 | 0.02 |
| 7337 | BANK1 levels | GCST90468421 | 0.02 |
| 7338 | ERBB2/FURIN ratio | GCST90314686 | 0.02 |
| 7339 | Cryptic phenotype that captures alpha-1-antitrypsin deficiency severity | GCST90101825 | 0.02 |
| 7340 | IGFBP4 levels | GCST90469530 | 0.02 |
| 7341 | IDP dMRI TBSS L3 Splenium of corpus callosum | GCST90004175 | 0.02 |
| 7342 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T99 | ECGU000099 | 0.02 |
| 7343 | Other intervertebral disk disorders | Other dorsopathies | UKBB00000612 | 0.02 |
| 7344 | X-21353 metabolite level | GCST90616708 | 0.02 |
| 7345 | IDP dMRI ProbtrackX ICVF cgc r | GCST90004380 | 0.02 |
| 7346 | Qualifications - CSEs or equivalent | Education | UKBB00000728 | 0.02 |
| 7347 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T473 | ECGA000473 | 0.02 |
| 7348 | CXCL3 levels | GCST90468931 | 0.02 |
| 7349 | HDGF levels | GCST90469442 | 0.02 |
| 7350 | Migraine, single triptan purchase ok & required. ICD-code if available is included | FING00000824 | 0.02 |
| 7351 | Salmon liking | GCST90094826 | 0.02 |
| 7352 | CHMP6 levels | GCST90468747 | 0.02 |
| 7353 | SDK2 levels | GCST90470562 | 0.02 |
| 7354 | Valine levels | GCST90500177 | 0.02 |
| 7355 | Treatment or medication use - ezetimibe (UKB data field 20003_1141192736) | GCST90042541 | 0.02 |
| 7356 | Hematocrit | GCST90278634 | 0.02 |
| 7357 | CEP85 levels | GCST90468716 | 0.02 |
| 7358 | Principal component-derived dietary pattern 7 | GCST90133012 | 0.02 |
| 7359 | GRAP2 levels | GCST90469399 | 0.02 |
| 7360 | Conjunctivitis | FING00000346 | 0.02 |
| 7361 | Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levels | GCST90060318 | 0.02 |
| 7362 | TSC22D1 levels | GCST90470973 | 0.02 |
| 7363 | T1 FreeSurfer aseg Right-Putamen | GCST90384163 | 0.02 |
| 7364 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502567 | 0.02 |
| 7365 | DNAJC21 levels | GCST90469016 | 0.02 |
| 7366 | GP6/SELP ratio | GCST90314970 | 0.02 |
| 7367 | IL10RB levels | GCST90469545 | 0.02 |
| 7368 | T1 FIRST volume L Hipp | GCST90383990 | 0.02 |
| 7369 | CCL17/GRK5 ratio | GCST90313687 | 0.02 |
| 7370 | Cancer of liver and intrahepatic bile duct (PheCode 155) | GCST90475568 | 0.02 |
| 7371 | DNAJA2 levels | GCST90469009 | 0.02 |
| 7372 | DTD1 levels | GCST90469045 | 0.02 |
| 7373 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditions | UKBB00000100 | 0.02 |
| 7374 | Waist circumference (UKB data field 48) | GCST90468182 | 0.02 |
| 7375 | Gamma glutamyltransferase | Blood biochemistry | UKBB00000275 | 0.02 |
| 7376 | CD40 levels | GCST90468633 | 0.02 |
| 7377 | RILPL2 levels | GCST90470470 | 0.02 |
| 7378 | BA-exvivo lh area BA45 | GCST90003215 | 0.02 |
| 7379 | Felt very upset when reminded of stressful experience in past month | Traumatic events | UKBB00000243 | 0.02 |
| 7380 | Nontoxic nodular goiter | endocrine/metabolic | UKBB00000529 | 0.02 |
| 7381 | KYAT1 levels | GCST90469721 | 0.02 |
| 7382 | CXCL9 levels | GCST90468935 | 0.02 |
| 7383 | Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093051 | 0.02 |
| 7384 | Androstenediol (3beta,17beta) monosulfate (1) levels | GCST90199872 | 0.02 |
| 7385 | PDGFB/PTPN6 ratio | GCST90315625 | 0.02 |
| 7386 | MOG/SEZ6L ratio | GCST90315477 | 0.02 |
| 7387 | IDP dMRI ProbtrackX ISOVF fmi | GCST90004536 | 0.02 |
| 7388 | aparc-DKTatlas lh volume supramarginal | GCST90002891 | 0.02 |
| 7389 | Extrapyramidal disease and abnormal movement disorders (PheCode 333) | GCST90475831 | 0.02 |
| 7390 | LPP levels | GCST90469790 | 0.02 |
| 7391 | DBNL levels | GCST90468951 | 0.02 |
| 7392 | SNAP29 levels | GCST90470692 | 0.02 |
| 7393 | CRIP2/SNCG ratio | GCST90314262 | 0.02 |
| 7394 | Arterial embolism and thrombosis of lower extremity artery | FING00000106 | 0.02 |
| 7395 | aparc-pial lh area superiorparietal | GCST90003169 | 0.02 |
| 7396 | Phenylalanine levels | GCST90499223 | 0.02 |
| 7397 | Blood cell traits latent factor 6 (red cell (and basophil)) | GCST90559248 | 0.02 |
| 7398 | QPCT/RNASET2 ratio | GCST90315758 | 0.02 |
| 7399 | Squamous cell carcinoma (PheCode 172.22) | GCST90475583 | 0.02 |
| 7400 | SHMT1 levels | GCST90470627 | 0.02 |
| 7401 | Lactate levels (UKB data field 23471) | GCST90269568 | 0.02 |
| 7402 | Calcific tendinitis of shoulder | FING00000235 | 0.02 |
| 7403 | Concentration of HDL particles (UKB data field 23430) | GCST90269527 | 0.02 |
| 7404 | Type 1 diabetes | GCST90013791 | 0.02 |
| 7405 | CRADD/HSPA1A ratio | GCST90314239 | 0.02 |
| 7406 | CSTB levels | GCST90012006 | 0.02 |
| 7407 | Placental weight (paternal genotype, adjusted for sex and gestational age) | GCST90275191 | 0.02 |
| 7408 | HippSubfield rh volume CA4-body | GCST90002705 | 0.02 |
| 7409 | DTI TBSS L2 Posterior thalamic radiation R | GCST90384504 | 0.02 |
| 7410 | NOTCH2 levels | GCST90470066 | 0.02 |
| 7411 | T1 CAT volume R RightPutamen | GCST90384101 | 0.02 |
| 7412 | CC2D1A/STAMBP ratio | GCST90313664 | 0.02 |
| 7413 | HLA-DRA levels | GCST90469458 | 0.02 |
| 7414 | Qualifications - A levels/AS levels or equivalent | Education | UKBB00000727 | 0.02 |
| 7415 | KIFBP levels | GCST90469683 | 0.02 |
| 7416 | Monounsaturated fatty acid levels | GCST90499090 | 0.02 |
| 7417 | CLEC1A/GPR37 ratio | GCST90314084 | 0.02 |
| 7418 | X-21467 levels | GCST90200594 | 0.02 |
| 7419 | LDL cholesterol | GCST90018741 | 0.02 |
| 7420 | PRG2 levels | GCST90470322 | 0.02 |
| 7421 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T92 | ECGU000092 | 0.02 |
| 7422 | CRACR2A levels | GCST90468853 | 0.02 |
| 7423 | APOC1 levels | GCST90468336 | 0.02 |
| 7424 | RGMB/THY1 ratio | GCST90315771 | 0.02 |
| 7425 | CD274 levels | GCST90274832 | 0.02 |
| 7426 | Body fat percentage (adjusted for testosterone and SHBG) x sex interaction | GCST90432181 | 0.02 |
| 7427 | BAIAP2/MME ratio | GCST90313453 | 0.02 |
| 7428 | PTGDS levels | GCST90470368 | 0.02 |
| 7429 | Reticulocyte count | GCST004622 | 0.02 |
| 7430 | CA3 levels | GCST90468512 | 0.02 |
| 7431 | aparc-a2009s lh volume G-precuneus | GCST90002954 | 0.02 |
| 7432 | NELL2 levels | GCST90470027 | 0.02 |
| 7433 | TNFSF11 levels | GCST90012044 | 0.02 |
| 7434 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T483 | ECGA000483 | 0.02 |
| 7435 | NT5E levels | GCST90470093 | 0.02 |
| 7436 | ACOX1/VSIR ratio | GCST90313155 | 0.02 |
| 7437 | HippSubfield lh volume hippocampal-fissure | GCST90002672 | 0.02 |
| 7438 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502645 | 0.02 |
| 7439 | STK24/TDRKH ratio | GCST90315893 | 0.02 |
| 7440 | FLT3 levels | GCST90469251 | 0.02 |
| 7441 | Oral glucose tolerance test-0h | GCST90566421 | 0.02 |
| 7442 | IGSF21 levels | GCST90469538 | 0.02 |
| 7443 | DNAJB1 levels | GCST90469012 | 0.02 |
| 7444 | AGRP levels | GCST90468256 | 0.02 |
| 7445 | CA13 levels | GCST90468508 | 0.02 |
| 7446 | MANSC1/PODXL2 ratio | GCST90315371 | 0.02 |
| 7447 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90499288 | 0.02 |
| 7448 | DTI autoptx MD fma tract | GCST90385230 | 0.02 |
| 7449 | CASP10/PRTFDC1 ratio | GCST90313627 | 0.02 |
| 7450 | Right-hemisphere default mode network to amygdala white-matter structural connectivity | GCST90302849 | 0.02 |
| 7451 | DTI TBSS FA Anterior corona radiata R | GCST90384402 | 0.02 |
| 7452 | PLA2G15/PRCP ratio | GCST90315661 | 0.02 |
| 7453 | EHMT2 levels | GCST90241442 | 0.02 |
| 7454 | PNLIPRP2 levels | GCST90470274 | 0.02 |
| 7455 | ARHGAP25 levels | GCST90468353 | 0.02 |
| 7456 | rfMRI connectivity (ICA100 edge 912) | GCST90005765 | 0.02 |
| 7457 | CCN2/VEGFC ratio | GCST90313719 | 0.02 |
| 7458 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477 | ECGU000477 | 0.02 |
| 7459 | KIAA0040 levels | GCST90422552 | 0.02 |
| 7460 | Triglycerides | Blood biochemistry | UKBB00000861 | 0.02 |
| 7461 | Creatinine levels | GCST90092815 | 0.02 |
| 7462 | Brugada syndrome | GCST90295916 | 0.02 |
| 7463 | Triglyceride to HDL cholesterol ratio | GCST90295951 | 0.02 |
| 7464 | Spells in hospital | Summary Administration | UKBB00000789 | 0.02 |
| 7465 | Other haemoglobinopathies | FING00001053 | 0.02 |
| 7466 | Diabetes mellitus | endocrine/metabolic | UKBB00000169 | 0.02 |
| 7467 | Ambidextrousness | GCST90013420 | 0.02 |
| 7468 | DTI TBSS L3 Genu of corpus callosum | GCST90384526 | 0.02 |
| 7469 | Insulin fold change during an oral glucose tolerance test | GCST90267568 | 0.02 |
| 7470 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T466 | ECGA000466 | 0.02 |
| 7471 | Ever felt worried, tense, or anxious for most of a month or longer | Anxiety | UKBB00000215 | 0.02 |
| 7472 | GMPR levels | GCST90469368 | 0.02 |
| 7473 | GSTA3 levels | GCST90469412 | 0.02 |
| 7474 | Omega-3 fatty acid levels | GCST90502440 | 0.02 |
| 7475 | ACP5 levels | GCST90468203 | 0.02 |
| 7476 | LTA4H levels | GCST90469812 | 0.02 |
| 7477 | APEX1/LSP1 ratio | GCST90313307 | 0.02 |
| 7478 | Cholesteryl Esters in IDL | GCST90497523 | 0.02 |
| 7479 | CETN2 levels | GCST90468721 | 0.02 |
| 7480 | AMBP levels | GCST90468288 | 0.02 |
| 7481 | C1QTNF1/COL18A1 ratio | GCST90313551 | 0.02 |
| 7482 | BIN2/EREG ratio | GCST90313503 | 0.02 |
| 7483 | Disorders of lipoprotein metabolism and other lipidaemias | FING00000442 | 0.02 |
| 7484 | Other hypertrophic and atrophic conditions (PheCode 701) | GCST90476197 | 0.02 |
| 7485 | CTRC/PLA2G1B ratio | GCST90314310 | 0.02 |
| 7486 | IDP dMRI ProbtrackX ISOVF cgc l | GCST90004529 | 0.02 |
| 7487 | Serum 25-Hydroxyvitamin D levels | GCST90000618 | 0.02 |
| 7488 | Omega-3 fatty acids levels | GCST90499139 | 0.02 |
| 7489 | Takes medication for blood clot/ pulmonary embolism/ deep vein thrombosis (DVT)? | GCST90475210 | 0.02 |
| 7490 | CDH5/ENG ratio | GCST90313954 | 0.02 |
| 7491 | Number of non-cancer illnesses (standard GWA) | GCST90267290 | 0.02 |
| 7492 | STAMBP/WWP2 ratio | GCST90315888 | 0.02 |
| 7493 | IDP T1 FAST ROIs R cerebellum IX | GCST90002586 | 0.02 |
| 7494 | wg lh intensity-contrast medialorbitofrontal | GCST90003805 | 0.02 |
| 7495 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475456 | 0.02 |
| 7496 | CD244/GP1BA ratio | GCST90313766 | 0.02 |
| 7497 | PLA2G4A/SNAP29 ratio | GCST90315669 | 0.02 |
| 7498 | Iridocyclitis | FING00000696 | 0.02 |
| 7499 | SLC5A8 levels | GCST90242850 | 0.02 |
| 7500 | FGFR4 levels | GCST90469234 | 0.02 |
| 7501 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditions | UKBB00000101 | 0.02 |
| 7502 | 1-arachidonoylglycerophosphoinositol levels | GCST90243754 | 0.02 |
| 7503 | Cucumber liking | GCST90094749 | 0.02 |
| 7504 | IDP SWI T2star right thalamus | GCST90003864 | 0.02 |
| 7505 | Total testosterone levels | GCST90239820 | 0.02 |
| 7506 | CD48/FCRL6 ratio | GCST90313840 | 0.02 |
| 7507 | AXIN1/ITGB1BP2 ratio | GCST90313412 | 0.02 |
| 7508 | Arm fat percentage (left) | Impedance measures | UKBB00000045 | 0.02 |
| 7509 | TFRC levels | GCST90470840 | 0.02 |
| 7510 | Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditions | UKBB00000369 | 0.02 |
| 7511 | F2R/SNX9 ratio | GCST90314736 | 0.02 |
| 7512 | SH2B3/SUGT1 ratio | GCST90315840 | 0.02 |
| 7513 | PCOLCE levels | GCST90470175 | 0.02 |
| 7514 | CLEC1B/RWDD1 ratio | GCST90314102 | 0.02 |
| 7515 | IL6R levels | GCST90469602 | 0.02 |
| 7516 | Lupus erythematosus | FING00000739 | 0.02 |
| 7517 | Other disorders of stomach and duodenum (PheCode 537) | GCST90476054 | 0.02 |
| 7518 | WASL levels | GCST90471070 | 0.02 |
| 7519 | GASK1A levels | GCST90469306 | 0.02 |
| 7520 | Ulcerative colitis | GCST90475322 | 0.02 |
| 7521 | neutrophil (absolute count, minimum, inv-norm transformed) | GCST90475532 | 0.02 |
| 7522 | FHIT/PRTFDC1 ratio | GCST90314823 | 0.02 |
| 7523 | T1 FreeSurfer BA rh BA4p exvivo area | GCST90385552 | 0.02 |
| 7524 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478 | ECGU000478 | 0.02 |
| 7525 | LGALS8 levels | GCST90469764 | 0.02 |
| 7526 | aparc-Desikan rh area superiorparietal | GCST90003135 | 0.02 |
| 7527 | MAVS/TBL1X ratio | GCST90315399 | 0.02 |
| 7528 | Ever depressed for a whole week | Mental health | UKBB00000214 | 0.02 |
| 7529 | SPARC/TACC3 ratio | GCST90315872 | 0.02 |
| 7530 | Ceramide_40:1_[M-H]1- levels | GCST90060198 | 0.02 |
| 7531 | PTGR1 levels | GCST90470370 | 0.02 |
| 7532 | TACC3 levels | GCST90470797 | 0.02 |
| 7533 | Carboplatin drug response (IC50) | GCST90011783 | 0.02 |
| 7534 | CST6 levels | GCST90468896 | 0.02 |
| 7535 | Spread type: Butter vs never use spread (UKB data field 1428) | GCST90132952 | 0.02 |
| 7536 | TGFB1 levels | GCST90470843 | 0.02 |
| 7537 | Prescriptions - doxazosin | alpha1-antagonist,alpha blocker | UKBB00000679 | 0.02 |
| 7538 | CD40LG/GP6 ratio | GCST90313822 | 0.02 |
| 7539 | Operation code - pilonidal sinus surgery (anal) | Operations | UKBB00000563 | 0.02 |
| 7540 | Plasma taurocholenate sulfate* levels in chronic kidney disease | GCST90266040 | 0.02 |
| 7541 | DTI TBSS MD Cingulum cingulate gyrus L | GCST90384607 | 0.02 |
| 7542 | ITGB1BP2 levels | GCST90469642 | 0.02 |
| 7543 | Overall health rating | General health | UKBB00000621 | 0.02 |
| 7544 | SCAMP3 levels | GCST90470532 | 0.02 |
| 7545 | NSFL1C/UBAC1 ratio | GCST90315565 | 0.02 |
| 7546 | SLA2 levels | GCST90470648 | 0.02 |
| 7547 | Radiotherapy (PheCode 196) | GCST90475605 | 0.02 |
| 7548 | Autoimmune hepatitis | GCST90018565 | 0.02 |
| 7549 | GM1 ganglioside (d18:1/16:0) levels | GCST90024724 | 0.02 |
| 7550 | FADD/GRAP2 ratio | GCST90314766 | 0.02 |
| 7551 | PPCDC/RWDD1 ratio | GCST90315704 | 0.02 |
| 7552 | Depression (broad) | GCST005902 | 0.02 |
| 7553 | Phospholipids in medium HDL | GCST90498641 | 0.02 |
| 7554 | Self-rated health | GCST006620 | 0.02 |
| 7555 | IDP T1 FIRST right caudate volume | GCST90002439 | 0.02 |
| 7556 | IDP dMRI TBSS L1 Splenium of corpus callosum | GCST90004079 | 0.02 |
| 7557 | OXCT1 levels | GCST90470138 | 0.02 |
| 7558 | Sphinganine-1-phosphate levels | GCST90199845 | 0.02 |
| 7559 | CNPY4 levels | GCST90468800 | 0.02 |
| 7560 | GRAP2/LACTB2 ratio | GCST90314980 | 0.02 |
| 7561 | Cataracts | GCST90018594 | 0.02 |
| 7562 | Insulin fold change during an oral glucose tolerance test (adjusted for BMI) | GCST90267567 | 0.02 |
| 7563 | LGALS7_LGALS7B/WFDC12 ratio | GCST90315317 | 0.02 |
| 7564 | ARSB levels | GCST90468369 | 0.02 |
| 7565 | Cholesteryl esters to total lipids ratio in very large HDL | GCST90093007 | 0.02 |
| 7566 | Cholesterol to Total Lipids in Small HDL percentage | GCST90499373 | 0.02 |
| 7567 | GORASP2 levels | GCST90469378 | 0.02 |
| 7568 | CDH17/SPINT1 ratio | GCST90313944 | 0.02 |
| 7569 | Principal component-derived dietary pattern 58 | GCST90133061 | 0.02 |
| 7570 | Saturated fatty acids levels | GCST90502185 | 0.02 |
| 7571 | TIE1 levels | GCST90470863 | 0.02 |
| 7572 | TXNRD1 levels | GCST90470994 | 0.02 |
| 7573 | CD160/CXCL16 ratio | GCST90313728 | 0.02 |
| 7574 | CIAPIN1/VEGFC ratio | GCST90314071 | 0.02 |
| 7575 | Mineral and other dietary supplements - Glucosamine | Medication | UKBB00000473 | 0.02 |
| 7576 | CASP2 levels | GCST90468544 | 0.02 |
| 7577 | T1 FreeSurfer BA rh BA3a exvivo thickness | GCST90385563 | 0.02 |
| 7578 | MELTF levels | GCST90469885 | 0.02 |
| 7579 | CD40/GLOD4 ratio | GCST90313814 | 0.02 |
| 7580 | ACYP2 levels | GCST90240187 | 0.02 |
| 7581 | SNAP23 levels | GCST90470690 | 0.02 |
| 7582 | IRAG2/TBC1D23 ratio | GCST90315191 | 0.02 |
| 7583 | HBEGF levels | GCST90012067 | 0.02 |
| 7584 | Parental longevity (combined parental age at death) | GCST006702 | 0.02 |
| 7585 | ANGPT1/SERPINE1 ratio | GCST90313269 | 0.02 |
| 7586 | Breast conditions, congenital or relating to hormones (PheCode 612) | GCST90476162 | 0.02 |
| 7587 | F-strong flavour liking (derived food-liking factor) | GCST90094851 | 0.02 |
| 7588 | Other hearing loss | FING00001056 | 0.02 |
| 7589 | RNF146 levels | GCST90421479 | 0.02 |
| 7590 | How are people in household related to participant - Husband, wife or partner | Household | UKBB00000330 | 0.02 |
| 7591 | CTRB1/PLA2G1B ratio | GCST90314307 | 0.02 |
| 7592 | NECTIN2/TNFRSF14 ratio | GCST90315531 | 0.02 |
| 7593 | Neoplasm of uncertain behavior of skin (PheCode 173) | GCST90475585 | 0.02 |
| 7594 | T1 CAT volume L LeftPutamen | GCST90384100 | 0.02 |
| 7595 | Other disorders of skin and subcutaneous tissue, not elsewhere classified | FING00001036 | 0.02 |
| 7596 | Phenylacetylglutamate levels | GCST90200069 | 0.02 |
| 7597 | Principal component-derived dietary pattern 21 | GCST90133026 | 0.02 |
| 7598 | Left-hemisphere default mode network to amygdala white-matter structural connectivity | GCST90302772 | 0.02 |
| 7599 | Leisure/social activities - Sports club or gym | Social support | UKBB00000402 | 0.02 |
| 7600 | CD46/SELP ratio | GCST90313834 | 0.02 |
| 7601 | Recent inability to stop or control worrying | Anxiety | UKBB00000742 | 0.02 |
| 7602 | CLEC1B/DIABLO ratio | GCST90314087 | 0.02 |
| 7603 | CEBPB/NADK ratio | GCST90314006 | 0.02 |
| 7604 | DCTN1/ERBIN ratio | GCST90314429 | 0.02 |
| 7605 | Obstructive chronic bronchitis | respiratory | UKBB00000546 | 0.02 |
| 7606 | IDP dMRI TBSS OD Anterior limb of internal capsule L | GCST90004419 | 0.02 |
| 7607 | DTI TBSS MD Superior fronto-occipital fasciculus L | GCST90384615 | 0.02 |
| 7608 | Other forms of systemic lupus erythematosus | FING00001051 | 0.02 |
| 7609 | Chronic venous insufficiency [CVI] (PheCode 456) | GCST90476016 | 0.02 |
| 7610 | Volume of left paralaminar nucleus | GCST90474895 | 0.02 |
| 7611 | MED18 levels | GCST90469880 | 0.02 |
| 7612 | F7 levels | GCST90469171 | 0.02 |
| 7613 | CD209/CLEC14A ratio | GCST90313749 | 0.02 |
| 7614 | Verbal-numerical reasoning | GCST003498 | 0.02 |
| 7615 | DNA methylation-estimated granulocyte proportions | GCST90014287 | 0.02 |
| 7616 | CEACAM21 levels | GCST90468694 | 0.02 |
| 7617 | DTI TBSS MD Superior corona radiata R | GCST90384596 | 0.02 |
| 7618 | Cholelithiasis | GCST90018599 | 0.02 |
| 7619 | X-17676 levels | GCST90200548 | 0.02 |
| 7620 | Mid-point of the five least active hours of the day | GCST90061434 | 0.02 |
| 7621 | T1 CAT volume L VIIIb | GCST90384130 | 0.02 |
| 7622 | Principal component-derived dietary pattern 35 | GCST90133040 | 0.02 |
| 7623 | CD2AP/USP8 ratio | GCST90313784 | 0.02 |
| 7624 | Hair colour (natural, before greying): Black (UKB data field 1747_5) | GCST90041840 | 0.02 |
| 7625 | CAMKK1/FOXO1 ratio | GCST90313613 | 0.02 |
| 7626 | Congenital malformations of ovaries, fallopian tubes and broad ligaments | FING00000337 | 0.02 |
| 7627 | Fasting glucose | GCST90002231 | 0.02 |
| 7628 | PSAP levels | GCST90470351 | 0.02 |
| 7629 | ACTA2 levels | GCST90468208 | 0.02 |
| 7630 | AMBP/HYOU1 ratio | GCST90313255 | 0.02 |
| 7631 | LAT/VASH1 ratio | GCST90315289 | 0.02 |
| 7632 | SHISA5 levels | GCST90470626 | 0.02 |
| 7633 | Monocyte count | GCST90025950 | 0.02 |
| 7634 | Obstructive sleep apnea (PheCode 327.32) | GCST90475825 | 0.02 |
| 7635 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502554 | 0.02 |
| 7636 | Free cholesterol levels in medium HDL | GCST90092896 | 0.02 |
| 7637 | Free cholesterol in IDL (UKB data field 23528) | GCST90269625 | 0.02 |
| 7638 | Phospholipids to total lipids ratio in very small VLDL | GCST90093037 | 0.02 |
| 7639 | Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82) | GCST90668526 | 0.02 |
| 7640 | ART3/GPC1 ratio | GCST90313361 | 0.02 |
| 7641 | Coffee consumption (cups per day) | GCST90132984 | 0.02 |
| 7642 | MAP2K6/NT5C3A ratio | GCST90315374 | 0.02 |
| 7643 | aparc-pial rh area fusiform | GCST90003180 | 0.02 |
| 7644 | Left-hemisphere limbic network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302731 | 0.02 |
| 7645 | Skin color (cheek, ITA value) | GCST90502780 | 0.02 |
| 7646 | aseg lh intensity VentralDC | GCST90003775 | 0.02 |
| 7647 | TNFRSF13B/TNFRSF9 ratio | GCST90315932 | 0.02 |
| 7648 | HEXIM1/TBL1X ratio | GCST90315053 | 0.02 |
| 7649 | DTI autoptx MD ilf l tract | GCST90385234 | 0.02 |
| 7650 | Other specified/unspecified inflammatory spondylopathies | FING00001109 | 0.02 |
| 7651 | Marzipan liking | GCST90094797 | 0.02 |
| 7652 | Triacylglycerol_56:6_[M+NH4]1+ levels | GCST90060553 | 0.02 |
| 7653 | PLA2G15/SMPDL3A ratio | GCST90315663 | 0.02 |
| 7654 | Clinical anxiety and depression (confirmatory factor analysis Factor 3) | GCST90309338 | 0.02 |
| 7655 | HYOU1/PTPRF ratio | GCST90315102 | 0.02 |
| 7656 | Androstenediol (3beta,17beta) disulfate (1) levels | GCST90199842 | 0.02 |
| 7657 | aparc-DKTatlas rh thickness lingual | GCST90003582 | 0.02 |
| 7658 | Diacylglycerol_34:2_[M+H-H2O]1+ levels | GCST90060178 | 0.02 |
| 7659 | DTI TBSS FA Sagittal stratum R | GCST90384410 | 0.02 |
| 7660 | CEACAM16 levels | GCST90468689 | 0.02 |
| 7661 | Triacylglycerol_53:4_[M+NH4]1+ levels | GCST90060524 | 0.02 |
| 7662 | Volume of left central nucleus | GCST90474961 | 0.02 |
| 7663 | Glomerular filtration rate (creatinine) | GCST003372 | 0.02 |
| 7664 | SPINK5 levels | GCST90470724 | 0.02 |
| 7665 | Plasma N-acetyltaurine levels in chronic kidney disease | GCST90265600 | 0.02 |
| 7666 | Number of treatments/medications taken | Medications | UKBB00000542 | 0.02 |
| 7667 | Glutamine levels (UKB data field 23461) | GCST90269558 | 0.02 |
| 7668 | Cholesterol levels in very large HDL | GCST90500322 | 0.02 |
| 7669 | Age completed full time education | Education | UKBB00000013 | 0.02 |
| 7670 | ITM2A levels | GCST90469653 | 0.01 |
| 7671 | GSTA1 levels | GCST90469411 | 0.01 |
| 7672 | Milk type used: Full cream (UKB data field 1418_1) | GCST90132938 | 0.01 |
| 7673 | DKK1/IPCEF1 ratio | GCST90314471 | 0.01 |
| 7674 | CLIP2/LAT2 ratio | GCST90314128 | 0.01 |
| 7675 | DNMBP/PTPN1 ratio | GCST90314517 | 0.01 |
| 7676 | Congenital malformations of genital organs | FING00000333 | 0.01 |
| 7677 | Type 1 diabetes with neurological manifestations (PheCode 250.14) | GCST90475664 | 0.01 |
| 7678 | T1 FreeSurfer DK rh lateraloccipital area | GCST90385699 | 0.01 |
| 7679 | HRC levels | GCST90469475 | 0.01 |
| 7680 | MPIG6B levels | GCST90469935 | 0.01 |
| 7681 | JAM3 levels | GCST90469660 | 0.01 |
| 7682 | Cardiometabolic multimorbidity | GCST90274723 | 0.01 |
| 7683 | Alanine aminotransferase | Blood biochemistry | UKBB00000018 | 0.01 |
| 7684 | CX3CL1/LAYN ratio | GCST90314325 | 0.01 |
| 7685 | Superficial cellulitis and abscess (PheCode 681) | GCST90476165 | 0.01 |
| 7686 | Total bilirubin levels (UKB data field 30840) | GCST90468104 | 0.01 |
| 7687 | Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels | GCST90060280 | 0.01 |
| 7688 | PMM2 levels | GCST90470270 | 0.01 |
| 7689 | Alcohol drinker status - Never | Alcohol | UKBB00000022 | 0.01 |
| 7690 | Type 2 diabetes | endocrine/metabolic | UKBB00000867 | 0.01 |
| 7691 | TNFRSF8/TNFRSF9 ratio | GCST90315940 | 0.01 |
| 7692 | Caries in Clefts patients | FING00000256 | 0.01 |
| 7693 | total creatine kinase (maximum, inv-norm transformed) | GCST90476410 | 0.01 |
| 7694 | General happiness with own health | Happiness and subjective well-being | UKBB00000281 | 0.01 |
| 7695 | Docosahexaenoic acid levels | GCST90502255 | 0.01 |
| 7696 | Monocyte count | Blood count | UKBB00000479 | 0.01 |
| 7697 | T1 FreeSurfer DK rh superiorparietal thickness | GCST90385751 | 0.01 |
| 7698 | Weight | GCST90278650 | 0.01 |
| 7699 | TNFRSF13B levels | GCST90470905 | 0.01 |
| 7700 | MAPRE3 levels | GCST90469859 | 0.01 |
| 7701 | Gastro-oesophageal reflux disease | FING00000564 | 0.01 |
| 7702 | KITLG levels | GCST90274833 | 0.01 |
| 7703 | Early-onset myasthenia gravis | GCST90093465 | 0.01 |
| 7704 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T73 | ECGU000073 | 0.01 |
| 7705 | Average diameter for VLDL particles | GCST90500279 | 0.01 |
| 7706 | ATP5IF1/HSPA1A ratio | GCST90313388 | 0.01 |
| 7707 | Anterior diffusion tensor imaging along the perivascular space index | GCST90455543 | 0.01 |
| 7708 | ICD10 O26.6: Liver disorders in pregnancy, childbirth and puerperium | GCST90454237 | 0.01 |
| 7709 | Colon cancer | GCST90011811 | 0.01 |
| 7710 | Volume of right medial nucleus | GCST90475045 | 0.01 |
| 7711 | Chronic sputum production | GCST90269902 | 0.01 |
| 7712 | Frailty (Factor 6 - Disability) | GCST90624052 | 0.01 |
| 7713 | Synonym | Fluid intelligence / reasoning | UKBB00000802 | 0.01 |
| 7714 | SNCG levels | GCST90470695 | 0.01 |
| 7715 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63) | GCST90320882 | 0.01 |
| 7716 | Coffee type - Decaffeinated coffee (any type) | Diet | UKBB00000139 | 0.01 |
| 7717 | HippSubfield lh volume Whole-hippocampus | GCST90002689 | 0.01 |
| 7718 | Processed meat intake | Diet | UKBB00000711 | 0.01 |
| 7719 | HSD11B1/SMPD1 ratio | GCST90315082 | 0.01 |
| 7720 | Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers) | FING00000754 | 0.01 |
| 7721 | Proline levels | GCST90243457 | 0.01 |
| 7722 | Biological Sibling: High cholesterol | GCST90476371 | 0.01 |
| 7723 | ICAM1 levels | GCST90469498 | 0.01 |
| 7724 | Excessive vomiting in pregnancy | FING00000523 | 0.01 |
| 7725 | KITLG levels | GCST90428432 | 0.01 |
| 7726 | CDKN1A/FXN ratio | GCST90313971 | 0.01 |
| 7727 | MAP2K6/MGMT ratio | GCST90315373 | 0.01 |
| 7728 | Concentration of large LDL particles (UKB data field 23530) | GCST90269627 | 0.01 |
| 7729 | X-11444 metabolite level | GCST90616545 | 0.01 |
| 7730 | Alanine transaminase (ALT, maximum, inv-norm transformed) | GCST90475109 | 0.01 |
| 7731 | FUOM levels | GCST90469276 | 0.01 |
| 7732 | Monocyte percentage of white cells | GCST004609 | 0.01 |
| 7733 | Left-hemisphere default mode network to hippocampus white-matter structural connectivity | GCST90302771 | 0.01 |
| 7734 | Plasma iron levels | GCST90100546 | 0.01 |
| 7735 | REST UKBBICA NODEamps25 0006 | GCST90385489 | 0.01 |
| 7736 | Glutamine levels | GCST90092818 | 0.01 |
| 7737 | Thick vs thin eyebrows | GCST006093 | 0.01 |
| 7738 | WWP2 levels | GCST90471080 | 0.01 |
| 7739 | Asthma and allergy | FING00000115 | 0.01 |
| 7740 | Estrone 3-sulfate metabolite level | GCST90616383 | 0.01 |
| 7741 | SERPINE1/SMAD1 ratio | GCST90315833 | 0.01 |
| 7742 | Cerebral amyloid angiopathy | FING00000262 | 0.01 |
| 7743 | EBI3_IL27/VCAM1 ratio | GCST90314572 | 0.01 |
| 7744 | CORO1A levels | GCST90468832 | 0.01 |
| 7745 | FUT8/SORT1 ratio | GCST90314892 | 0.01 |
| 7746 | ANGPT1/EGF ratio | GCST90313264 | 0.01 |
| 7747 | Drink temperature | GCST90133002 | 0.01 |
| 7748 | CNTNAP2/DPP6 ratio | GCST90314168 | 0.01 |
| 7749 | HBEGF/YES1 ratio | GCST90315039 | 0.01 |
| 7750 | CD74/DLL1 ratio | GCST90313891 | 0.01 |
| 7751 | SEMA4D/TXNDC5 ratio | GCST90315824 | 0.01 |
| 7752 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T488 | ECGA000488 | 0.01 |
| 7753 | Acquired hypothyroidism (PheCode 244.2) | GCST90475650 | 0.01 |
| 7754 | Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093045 | 0.01 |
| 7755 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T77 | ECGU000077 | 0.01 |
| 7756 | LGALS8/SOD2 ratio | GCST90315320 | 0.01 |
| 7757 | Bilirubin (E,Z or Z,E) levels | GCST90243750 | 0.01 |
| 7758 | CC2D1A/STIP1 ratio | GCST90313665 | 0.01 |
| 7759 | Current Smoker | FING00000371 | 0.01 |
| 7760 | Moderate to vigorous physical activity duration | GCST90061422 | 0.01 |
| 7761 | Mean corpuscular hemoglobin concentration | GCST90002329 | 0.01 |
| 7762 | Human herpes virus 7 U14 antibody levels | GCST90006909 | 0.01 |
| 7763 | ATP5IF1 levels | GCST90468392 | 0.01 |
| 7764 | ASAH2 levels | GCST90242098 | 0.01 |
| 7765 | Cholesterol in medium VLDL (UKB data field 23505) | GCST90269602 | 0.01 |
| 7766 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T472 | ECGA000472 | 0.01 |
| 7767 | Glycerophosphorylcholine (GPC) levels | GCST90199629 | 0.01 |
| 7768 | Disorders of bilirubin excretion (PheCode 277.4) | GCST90475756 | 0.01 |
| 7769 | Other arthrosis | FING00000965 | 0.01 |
| 7770 | Degree of unsaturation | GCST90502230 | 0.01 |
| 7771 | SERPINA9 levels | GCST90470588 | 0.01 |
| 7772 | Depression | GCST003769 | 0.01 |
| 7773 | High light scatter reticulocyte count | GCST90002385 | 0.01 |
| 7774 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T483 | ECGU000483 | 0.01 |
| 7775 | T1 FreeSurfer aseg Brain-Stem | GCST90384149 | 0.01 |
| 7776 | MGLL/PLA2G4A ratio | GCST90315439 | 0.01 |
| 7777 | Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483) | GCST90269580 | 0.01 |
| 7778 | Ulcer of lower limb, not elsewhere classified | FING00001385 | 0.01 |
| 7779 | MAX levels | GCST90469867 | 0.01 |
| 7780 | LAT levels | GCST90469741 | 0.01 |
| 7781 | Melanoma in situ (controls excluding all cancers) | FING00000803 | 0.01 |
| 7782 | IDP T1 FAST ROIs R ventral striatum | GCST90002560 | 0.01 |
| 7783 | Lateral epicondylitis | FING00000715 | 0.01 |
| 7784 | T1 FIRST volume L Puta | GCST90383987 | 0.01 |
| 7785 | CASP10 levels | GCST90468542 | 0.01 |
| 7786 | IDP T1 FAST ROIs L cerebellum V | GCST90002564 | 0.01 |
| 7787 | aparc-DKTatlas rh area superiorparietal | GCST90003292 | 0.01 |
| 7788 | CCN5 levels | GCST90468591 | 0.01 |
| 7789 | Trouble falling asleep when you first go to bed | GCST90476385 | 0.01 |
| 7790 | T1 FreeSurfer aseg Left-choroid-plexus | GCST90384156 | 0.01 |
| 7791 | Plasma glycocholenate sulfate* levels in chronic kidney disease | GCST90265291 | 0.01 |
| 7792 | Monounsaturated fatty acid levels | GCST90502029 | 0.01 |
| 7793 | Lamb liking | GCST90094790 | 0.01 |
| 7794 | AARSD1/PIK3AP1 ratio | GCST90313129 | 0.01 |
| 7795 | Radial styloid tenosynovitis [de Quervain] | FING00001237 | 0.01 |
| 7796 | Glucosamine medication | FING00000584 | 0.01 |
| 7797 | Sleep apnea syndrome | GCST90267361 | 0.01 |
| 7798 | APOB/APOA1 ratio | GCST90497158 | 0.01 |
| 7799 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T40 | ECGA000040 | 0.01 |
| 7800 | CPXM1/VEGFC ratio | GCST90314223 | 0.01 |
| 7801 | CRELD2/TXNDC5 ratio | GCST90314259 | 0.01 |
| 7802 | Diseases of liver | FING00000425 | 0.01 |
| 7803 | Chronic renal failure [CKD] (PheCode 585.3) | GCST90476123 | 0.01 |
| 7804 | IRAK4 levels | GCST90469628 | 0.01 |
| 7805 | Biological Mother: High blood pressure | GCST90475490 | 0.01 |
| 7806 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T432 | ECGU000432 | 0.01 |
| 7807 | CDKN2D/FOXO1 ratio | GCST90313985 | 0.01 |
| 7808 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T465 | ECGA000465 | 0.01 |
| 7809 | Phenylalanine levels (UKB data field 23468) | GCST90269565 | 0.01 |
| 7810 | Number of operations, self-reported | Operations | UKBB00000539 | 0.01 |
| 7811 | Cholesteryl Esters to Total Lipids in Small VLDL percentage | GCST90499804 | 0.01 |
| 7812 | IDP dMRI ProbtrackX FA ptr r | GCST90003945 | 0.01 |
| 7813 | DAG1/MGLL ratio | GCST90314377 | 0.01 |
| 7814 | PCDH17/ROBO1 ratio | GCST90315604 | 0.01 |
| 7815 | aparc-DKTatlas lh area fusiform | GCST90003239 | 0.01 |
| 7816 | OPLAH levels | GCST90470127 | 0.01 |
| 7817 | Salty food liking | GCST90094828 | 0.01 |
| 7818 | GAS6/NOTCH1 ratio | GCST90314918 | 0.01 |
| 7819 | Loud music exposure frequency | Hearing | UKBB00000410 | 0.01 |
| 7820 | DSG3/SPINK5 ratio | GCST90314561 | 0.01 |
| 7821 | C4BPB levels | GCST90468499 | 0.01 |
| 7822 | LCAT levels | GCST90469745 | 0.01 |
| 7823 | Urinary albumin excretion | GCST006586 | 0.01 |
| 7824 | Obesity, other/unspecified | FING00000898 | 0.01 |
| 7825 | Severe, life-threatening illness (confirmatory factor analysis Factor 20) | GCST90309354 | 0.01 |
| 7826 | LAMP3 levels | GCST90469735 | 0.01 |
| 7827 | APOL1 levels | GCST90468341 | 0.01 |
| 7828 | Phospholipids in small HDL | GCST90499478 | 0.01 |
| 7829 | Sphingomyelin_34:2_[M+H]1+ levels | GCST90060235 | 0.01 |
| 7830 | Trans-2-hexenoylglycine metabolite level | GCST90616136 | 0.01 |
| 7831 | SH2D1A levels | GCST90470617 | 0.01 |
| 7832 | Osteochondrodysplasia with defects of growth of tubular bones and spine | FING00000910 | 0.01 |
| 7833 | Other bacterial diseases | FING00000968 | 0.01 |
| 7834 | STC1 levels | GCST90470761 | 0.01 |
| 7835 | X-21286 levels | GCST90200562 | 0.01 |
| 7836 | Hyperplasia of prostate | FING00000635 | 0.01 |
| 7837 | Left-hemisphere limbic network to right-hemisphere default mode network white-matter structural connectivity | GCST90302735 | 0.01 |
| 7838 | Crohns disease | GCST90468121 | 0.01 |
| 7839 | DUSP3 levels | GCST90469053 | 0.01 |
| 7840 | IRAK1/NFATC1 ratio | GCST90315194 | 0.01 |
| 7841 | Hereditary and idiopathic peripheral neuropathy (PheCode 356) | GCST90475844 | 0.01 |
| 7842 | Tense / 'highly strung' | Mental health | UKBB00000815 | 0.01 |
| 7843 | Gestational diabetes mellitus | GCST90566419 | 0.01 |
| 7844 | PIK3IP1 levels | GCST90470234 | 0.01 |
| 7845 | Free Cholesterol to Total Lipids in Large HDL percentage | GCST90497793 | 0.01 |
| 7846 | MYL3 levels | GCST90469977 | 0.01 |
| 7847 | Illnesses of siblings - High blood pressure | Family history | UKBB00000352 | 0.01 |
| 7848 | CCL5/LAMA4 ratio | GCST90313703 | 0.01 |
| 7849 | Phospholipid levels in HDL | GCST90092827 | 0.01 |
| 7850 | LBR/POLR2F ratio | GCST90315297 | 0.01 |
| 7851 | CALCOCO1/IKBKG ratio | GCST90313602 | 0.01 |
| 7852 | Cholecystectomy | FING00000273 | 0.01 |
| 7853 | NUBP1 levels | GCST90470100 | 0.01 |
| 7854 | IDP SWI T2star right putamen | GCST90003868 | 0.01 |
| 7855 | Dihexosylceramide (d18:1/22:0) levels | GCST90025348 | 0.01 |
| 7856 | CTRL levels | GCST90468907 | 0.01 |
| 7857 | Single spontaneous delivery | FING00001307 | 0.01 |
| 7858 | Left-hemisphere control network to left-hemisphere default mode network white-matter structural connectivity | GCST90302744 | 0.01 |
| 7859 | Right-hemisphere somatomotor network to pallidum white-matter structural connectivity | GCST90302797 | 0.01 |
| 7860 | Gout | GCST90399701 | 0.01 |
| 7861 | IDP dMRI TBSS ICVF Superior cerebellar peduncle L | GCST90004340 | 0.01 |
| 7862 | CD99/CD99L2 ratio | GCST90313923 | 0.01 |
| 7863 | aparc-Desikan rh thickness lingual | GCST90003491 | 0.01 |
| 7864 | Asthma (childhood onset) | GCST007800 | 0.01 |
| 7865 | Phospholipids in very large VLDL | GCST90500647 | 0.01 |
| 7866 | DAAM1 levels | GCST90468941 | 0.01 |
| 7867 | AXIN1/SRPK2 ratio | GCST90313417 | 0.01 |
| 7868 | Prurigo nodularis | FING00001220 | 0.01 |
| 7869 | PARP1 levels | GCST90470160 | 0.01 |
| 7870 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T76 | ECGU000076 | 0.01 |
| 7871 | CC2D1A/TMSB10 ratio | GCST90313667 | 0.01 |
| 7872 | Fresh fruit consumption | GCST90132979 | 0.01 |
| 7873 | CFHR1 levels | GCST90618503 | 0.01 |
| 7874 | Pilonidal cyst | FING00001167 | 0.01 |
| 7875 | Irregular menstrual cycle/bleeding | genitourinary | UKBB00000379 | 0.01 |
| 7876 | HSPB1/PLIN3 ratio | GCST90315088 | 0.01 |
| 7877 | DIABLO/VSIR ratio | GCST90314470 | 0.01 |
| 7878 | Cholesterol in very small VLDL (UKB data field 23519) | GCST90269616 | 0.01 |
| 7879 | Job SOC coding: Heavy goods vehicle drivers (UKB data field 22617_8211) | GCST90043552 | 0.01 |
| 7880 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502155 | 0.01 |
| 7881 | CD58/ROR1 ratio | GCST90313854 | 0.01 |
| 7882 | IL2RB levels | GCST90469586 | 0.01 |
| 7883 | APOA1 levels | GCST90092808 | 0.01 |
| 7884 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502414 | 0.01 |
| 7885 | CKAP4/IL4R ratio | GCST90314072 | 0.01 |
| 7886 | CRACR2A/LBR ratio | GCST90314228 | 0.01 |
| 7887 | Beans liking | GCST90094699 | 0.01 |
| 7888 | F-sodas liking (derived food-liking factor) | GCST90094842 | 0.01 |
| 7889 | FCN1 levels | GCST90469203 | 0.01 |
| 7890 | CD40LG/SERPINE1 ratio | GCST90313826 | 0.01 |
| 7891 | COL18A1/RETN ratio | GCST90314170 | 0.01 |
| 7892 | SORT1 levels | GCST90470710 | 0.01 |
| 7893 | CRKL/DBNL ratio | GCST90314263 | 0.01 |
| 7894 | KITLG levels | GCST90469691 | 0.01 |
| 7895 | SDC4/WWP2 ratio | GCST90315821 | 0.01 |
| 7896 | White blood cell count | GCST90002407 | 0.01 |
| 7897 | CTSZ/HSPG2 ratio | GCST90314318 | 0.01 |
| 7898 | DAB2/GRAP2 ratio | GCST90314364 | 0.01 |
| 7899 | ENO2/RWDD1 ratio | GCST90314667 | 0.01 |
| 7900 | DTI TBSS L3 Sagittal stratum L | GCST90384555 | 0.01 |
| 7901 | Episodal and paroxysmal disorders | FING00000514 | 0.01 |
| 7902 | CD274 levels | GCST90468613 | 0.01 |
| 7903 | CDKN1A levels | GCST90468684 | 0.01 |
| 7904 | CCN2/TACC3 ratio | GCST90313717 | 0.01 |
| 7905 | aseg rh volume Accumbens-area | GCST90002643 | 0.01 |
| 7906 | INPPL1 levels | GCST90469619 | 0.01 |
| 7907 | DCXR levels | GCST90468964 | 0.01 |
| 7908 | Spirits liking | GCST90094848 | 0.01 |
| 7909 | HMBS/PKLR ratio | GCST90315063 | 0.01 |
| 7910 | Spread type: Flora Pro-Active/Benecol (UKB data field 1428_2) | GCST90132957 | 0.01 |
| 7911 | Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501092 | 0.01 |
| 7912 | Pure hyperglyceridaemia | FING00001231 | 0.01 |
| 7913 | Concentration of small HDL particles | GCST90499464 | 0.01 |
| 7914 | T1 FreeSurfer DKT rh lateraloccipital area | GCST90384295 | 0.01 |
| 7915 | CD46/SIAE ratio | GCST90313835 | 0.01 |
| 7916 | Waist circumference | Body size measures | UKBB00000904 | 0.01 |
| 7917 | Acute pancreatitis | FING00000027 | 0.01 |
| 7918 | Left-hemisphere control network to pallidum white-matter structural connectivity | GCST90302755 | 0.01 |
| 7919 | IDP SWI T2star right pallidum | GCST90003870 | 0.01 |
| 7920 | HippSubfield rh volume CA1-head | GCST90002696 | 0.01 |
| 7921 | High light scatter reticulocyte count | Blood count | UKBB00000326 | 0.01 |
| 7922 | PODXL2/SDC1 ratio | GCST90315701 | 0.01 |
| 7923 | PKLR/UBAC1 ratio | GCST90315660 | 0.01 |
| 7924 | IL12B levels | GCST90274798 | 0.01 |
| 7925 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90501042 | 0.01 |
| 7926 | Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers) | FING00001067 | 0.01 |
| 7927 | aparc-DKTatlas lh area supramarginal | GCST90003263 | 0.01 |
| 7928 | Other disorders of synovium, tendon, and bursa (PheCode 727) | GCST90476241 | 0.01 |
| 7929 | IDP T1 FAST ROIs L ventral striatum | GCST90002559 | 0.01 |
| 7930 | Non-insulin-dependent diabetes mellitus | Diabetes mellitus | UKBB00000524 | 0.01 |
| 7931 | Activities undertaken to treat anxiety | Anxiety | UKBB00000009 | 0.01 |
| 7932 | APP/CCL28 ratio | GCST90313317 | 0.01 |
| 7933 | Type 1 diabetes | GCST90014023 | 0.01 |
| 7934 | CRTAM/PDCD1 ratio | GCST90314279 | 0.01 |
| 7935 | Snoring | GCST009762 | 0.01 |
| 7936 | CRH levels | GCST90468862 | 0.01 |
| 7937 | VSIG4 levels | GCST90471052 | 0.01 |
| 7938 | HSPA1A levels | GCST90469487 | 0.01 |
| 7939 | Cholelithiasis | FING00000275 | 0.01 |
| 7940 | ATXN10/PRTFDC1 ratio | GCST90313398 | 0.01 |
| 7941 | EGF/MANF ratio | GCST90314609 | 0.01 |
| 7942 | Hearing difficulty with background noise | GCST90245775 | 0.01 |
| 7943 | ALDH1A1/CA3 ratio | GCST90313244 | 0.01 |
| 7944 | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) levels | GCST90199858 | 0.01 |
| 7945 | Body mass index (UKB data field 21001) | GCST90468161 | 0.01 |
| 7946 | Total lipids in medium HDL (UKB data field 23566) | GCST90269663 | 0.01 |
| 7947 | Intended management of patient (recoded) - One or more nights hospital stay | Summary Administration | UKBB00000367 | 0.01 |
| 7948 | Polyglandular dysfunction | FING00001186 | 0.01 |
| 7949 | Worry | GCST006478 | 0.01 |
| 7950 | BIN2 levels | GCST90468445 | 0.01 |
| 7951 | Other disorders of eye and adnexa | FING00001025 | 1.00e-02 |
| 7952 | N-acetylcarnosine levels | GCST90199926 | 9.99e-03 |
| 7953 | Free cholesterol to total lipids ratio in large VLDL | GCST90092873 | 9.98e-03 |
| 7954 | Rheumatoid arthritis (PheCode 714.1) | GCST90476230 | 9.97e-03 |
| 7955 | aparc-Desikan lh area fusiform | GCST90003079 | 9.96e-03 |
| 7956 | Arthropathy in ulcerative colitis | FING00000110 | 9.96e-03 |
| 7957 | Snoring | Sleep | UKBB00000784 | 9.92e-03 |
| 7958 | FGF21 levels | GCST90469222 | 9.92e-03 |
| 7959 | C20:4 Lysophosphatidylcholine levels in chronic kidney disease | GCST90257570 | 9.92e-03 |
| 7960 | RELT/TNFRSF1A ratio | GCST90315767 | 9.89e-03 |
| 7961 | Attention deficit hyperactivity disorder | GCST90568441 | 9.87e-03 |
| 7962 | GKN1 levels | GCST90469353 | 9.87e-03 |
| 7963 | F-oily fish liking (derived food-liking factor) | GCST90094804 | 9.85e-03 |
| 7964 | 3-hydroxydecanoate metabolite level | GCST90615472 | 9.83e-03 |
| 7965 | IDP T1 FAST ROIs L cerebellum VIIIa | GCST90002578 | 9.83e-03 |
| 7966 | CRTAM/KLRD1 ratio | GCST90314277 | 9.82e-03 |
| 7967 | Hallux rigidus | FING00000600 | 9.80e-03 |
| 7968 | wg lh intensity-contrast pericalcarine | GCST90003812 | 9.80e-03 |
| 7969 | Saturated fatty acids to total fatty acids percentage | GCST90502701 | 9.79e-03 |
| 7970 | ANXA4/CA13 ratio | GCST90313290 | 9.79e-03 |
| 7971 | Mild obesity-related type 2 diabetes | GCST90026415 | 9.79e-03 |
| 7972 | aparc-pial rh area precuneus | GCST90003198 | 9.79e-03 |
| 7973 | TYMP levels | GCST90470996 | 9.77e-03 |
| 7974 | AHSP/BLVRB ratio | GCST90313214 | 9.76e-03 |
| 7975 | ARHGAP1/SPARC ratio | GCST90313344 | 9.75e-03 |
| 7976 | Left-hemisphere visual network to caudate white-matter structural connectivity | GCST90302663 | 9.74e-03 |
| 7977 | Unstable angina (intermediate coronary syndrome) | circulatory system | UKBB00000883 | 9.74e-03 |
| 7978 | Rheumatoid arthritis | GCST90018690 | 9.73e-03 |
| 7979 | T1 FreeSurfer DKT rh lateraloccipital volume | GCST90384357 | 9.72e-03 |
| 7980 | BIN1 levels | GCST90090757 | 9.72e-03 |
| 7981 | CEP43/MPHOSPH8 ratio | GCST90314019 | 9.71e-03 |
| 7982 | ARHGAP30 levels | GCST90468354 | 9.69e-03 |
| 7983 | CALCOCO1/CRACR2A ratio | GCST90313598 | 9.69e-03 |
| 7984 | RETN levels | GCST90470457 | 9.68e-03 |
| 7985 | ENPP2/TNFRSF11B ratio | GCST90314672 | 9.68e-03 |
| 7986 | Ulcerative colitis | GCST004133 | 9.68e-03 |
| 7987 | STX6 levels | GCST90470774 | 9.67e-03 |
| 7988 | FSTL3 levels | GCST90469272 | 9.67e-03 |
| 7989 | Estradiol levels | GCST90020091 | 9.66e-03 |
| 7990 | EIF1AX levels | GCST90241120 | 9.66e-03 |
| 7991 | PAPL levels | GCST90427208 | 9.64e-03 |
| 7992 | Alcohol usually taken with meals (UKB data field 1618) | GCST90133004 | 9.63e-03 |
| 7993 | Red blood cell count | GCST90018751 | 9.61e-03 |
| 7994 | MITD1 levels | GCST90469910 | 9.61e-03 |
| 7995 | Gamma-glutamylglycine levels | GCST90199741 | 9.60e-03 |
| 7996 | aparc-a2009s lh volume S-intrapariet+P-trans | GCST90002980 | 9.59e-03 |
| 7997 | Liver enzyme levels (gamma-glutamyl transferase) | GCST90013407 | 9.59e-03 |
| 7998 | aparc-a2009s lh area S-orbital-med-olfact | GCST90003359 | 9.56e-03 |
| 7999 | Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk | FING00000150 | 9.55e-03 |
| 8000 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90500975 | 9.54e-03 |